Back to search

Article

5-fluorouracil Synergized with Raloxifene and Cytosine β-D-arabinofuranoside to Combat Colorectal Cancers in vitro via Controlling Lipolysis

2016-12-15

Abstract excerpt

Background: Colorectal cancers (CRCs) are the 3rd leading mortality cause in the states. Raloxifene (RX) was recently approved for cancer prevention. Therefore, 5-flurouracil (FU), a DNA blocker, stimulates apoptotic cascade in CRC cells. Unfortunately, many of the therapies that use FU and RX are likely to become ineffective due to drug resistance. Therefore, providing cytosine-$-D-arabinoside (CYT), an S-phase s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
583e002a-7958-5f1d-80c5-e983539fda6a
DOI
10.3923/jpt.2017.14.23
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
5-fluorouracil Synergized with Raloxifene and Cytosine β-D-arabinofuranoside to Combat Colorectal Cancers in vitro via Controlling LipolysisDOI 10.3923/jpt.2017.14.23
Select a neighboring publication to make it the new centre.